Table 1.
Baseline demographics and procedural characteristics.
| IFN beta-1a N = 27 |
Placebo N = 11 |
p value | |
|---|---|---|---|
| Demographics | |||
| Age | 73.4 (SD, 9.6) | 73.9 (SD, 7.6) | 0.87 |
| Sex (male) | 85% | 100% | 0.30 |
| Hypertension | 16 (59%) | 5 (46%) | 0.49 |
| Atrial fibrillation | 4 (15%) | 4 (36%) | 0.20 |
| Coronary artery disease | 4 (15%) | 1 (9%) | 1.00 |
| Hypercholesterolemia | 9 (33%) | 3 (27%) | 1.00 |
| Diabetes | 5 (19%) | 2 (18%) | 1.00 |
| COPD | 5 (19%) | 2 (18%) | 1.00 |
| Asthma | 3 (11%) | 1 (9%) | 1.00 |
| Major surgical features | |||
| Duration of surgery (min) | 186 (SD, 76) | 169 (SD, 55) | 0.49 |
| RBC substitution (mL) | 1573 (SD, 946) | 1378 (SD, 972) | 0.57 |
| Platelet substitution (mL) | 357 (SD, 603) | 173 (SD, 212) | 0.18 |
| Total volume substitution (mL) | 7159 (SD, 4133) | 6294 (SD, 1938) | 0.39 |
| Left renal vein ligated | 3 (11%) | 0 (0%) | 0.54 |
| Clamp above the renal arteries | 2 (7%) | 1 (9%) | 1.00 |
| Open abdomen | 13 (48%) | 3 (27%) | 0.30 |
COPD chronic obstructive pulmonary disease, RBC red blood cell.